Arunjyoti Bio [ABVL] vs Hinduja Global [HGS] Detailed Stock Comparison
Arunjyoti Bio
BSE
Loading...
Hinduja Global
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Arunjyoti Bio wins in 6 metrics, Hinduja Global wins in 12 metrics, with 0 ties. Hinduja Global appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Arunjyoti Bio | Hinduja Global | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 55.46 | 60.39 | Arunjyoti Bio |
| Price-to-Book Ratio | 5.10 | 0.30 | Hinduja Global |
| Debt-to-Equity Ratio | 80.95 | 24.74 | Hinduja Global |
| PEG Ratio | 1.28 | -0.68 | Hinduja Global |
| EV/EBITDA | 37.33 | 0.45 | Hinduja Global |
| Profit Margin (TTM) | -4.34% | -0.61% | Hinduja Global |
| Operating Margin (TTM) | 31.87% | -9.43% | Arunjyoti Bio |
| EBITDA Margin (TTM) | 31.87% | N/A | N/A |
| Return on Equity | -5.63% | 1.55% | Hinduja Global |
| Return on Assets (TTM) | -3.06% | 1.09% | Hinduja Global |
| Free Cash Flow (TTM) | $-44.22M | $2.14B | Hinduja Global |
| Dividend Yield | N/A | 1.29% | N/A |
| 1-Year Return | -26.25% | -36.35% | Arunjyoti Bio |
| Price-to-Sales Ratio (TTM) | 6.42 | 0.54 | Hinduja Global |
| Enterprise Value | $1.96B | $1.55B | Arunjyoti Bio |
| EV/Revenue Ratio | 7.39 | 0.04 | Hinduja Global |
| Gross Profit Margin (TTM) | 92.57% | 97.58% | Hinduja Global |
| Revenue per Share (TTM) | $1 | $945 | Hinduja Global |
| Earnings per Share (Diluted) | $-0.08 | $-17.24 | Arunjyoti Bio |
| Beta (Stock Volatility) | -0.20 | 0.29 | Arunjyoti Bio |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Arunjyoti Bio vs Hinduja Global Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Arunjyoti Bio | -0.44% | -18.41% | 27.69% | 43.10% | -24.48% | -52.57% |
| Hinduja Global | -2.06% | -0.55% | -3.70% | -10.20% | 4.22% | -28.79% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Arunjyoti Bio | -26.25% | 121.60% | 1,041.25% | 375.52% | 241.95% | 383.07% |
| Hinduja Global | -36.35% | -61.40% | 39.85% | 118.91% | 20.48% | -69.13% |
News Based Sentiment: Arunjyoti Bio vs Hinduja Global
Arunjyoti Bio
News based Sentiment: NEGATIVE
The month of October 2025 was largely negative for Arunjyoti Bio Ventures, characterized by significant share price declines over both six-month and one-year periods. While the company maintains a neutral technical rating and is being compared to its peers, the overall trend suggests investor concern and warrants caution.
Hinduja Global
News based Sentiment: NEGATIVE
The month of October 2025 brought disappointing financial results for HGS, including a revenue decline and a substantial net loss. Coupled with a 'Strong Sell' recommendation from an analyst, these developments significantly weaken the investment case and suggest increased risk for investors. While some positive signals exist, the overall narrative is decidedly negative.
Performance & Financial Health Analysis: Arunjyoti Bio vs Hinduja Global
| Metric | ABVL | HGS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.70B | ₹23.49B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 169,245 | 13,060 |
| 90 Day Avg. Volume | 387,234 | 13,539 |
| Last Close | ₹9.09 | ₹493.80 |
| 52 Week Range | ₹5.05 - ₹20.95 | ₹437.00 - ₹803.35 |
| % from 52W High | -56.62% | -38.53% |
| All-Time High | ₹30.07 (Jan 15, 2024) | ₹3,465.20 (May 15, 2006) |
| % from All-Time High | -69.77% | -85.75% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.14% | -0.03% |
| Quarterly Earnings Growth | 0.40% | -0.90% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | -0.01% |
| Operating Margin (TTM) | 0.32% | -0.09% |
| Return on Equity (TTM) | -0.06% | 0.02% |
| Debt to Equity (MRQ) | 80.95 | 24.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1.79 | ₹1,658.97 |
| Cash per Share (MRQ) | ₹0.03 | ₹920.51 |
| Operating Cash Flow (TTM) | ₹-12,115,000 | ₹-2,627,000,000 |
| Levered Free Cash Flow (TTM) | ₹-18,215,000 | ₹1.21B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.29% |
| Last 12-Month Dividend | N/A | ₹7.00 |
Valuation & Enterprise Metrics Analysis: Arunjyoti Bio vs Hinduja Global
| Metric | ABVL | HGS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 55.46 | 60.39 |
| Forward P/E | N/A | 4.68 |
| PEG Ratio | 1.28 | -0.68 |
| Price to Sales (TTM) | 6.42 | 0.54 |
| Price to Book (MRQ) | 5.10 | 0.30 |
| Market Capitalization | ||
| Market Capitalization | ₹1.70B | ₹23.49B |
| Enterprise Value | ₹1.96B | ₹1.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.39 | 0.04 |
| Enterprise to EBITDA | 37.33 | 0.45 |
| Risk & Other Metrics | ||
| Beta | -0.20 | 0.29 |
| Book Value per Share (MRQ) | ₹1.79 | ₹1,658.97 |
Financial Statements Comparison: Arunjyoti Bio vs Hinduja Global
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ABVL | HGS |
|---|---|---|
| Revenue/Sales | ₹87.12M | ₹10.56B |
| Cost of Goods Sold | ₹6.47M | ₹255.60M |
| Gross Profit | ₹80.65M | ₹10.31B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹27.77M | ₹-996.10M |
| EBITDA | ₹36.06M | ₹1.60B |
| Pre-Tax Income | ₹21.69M | ₹-264.80M |
| Income Tax | ₹-1.95M | ₹198.50M |
| Net Income (Profit) | ₹23.64M | ₹111.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ABVL | HGS |
|---|---|---|
| Cash & Equivalents | ₹5.92M | ₹7.52B |
| Total Current Assets | ₹147.98M | ₹74.70B |
| Total Current Liabilities | ₹52.90M | ₹23.26B |
| Long-Term Debt | ₹214.50M | ₹7.48B |
| Total Shareholders Equity | ₹323.80M | ₹78.55B |
| Retained Earnings | ₹-30.59M | ₹65.17B |
| Property, Plant & Equipment | ₹71.31M | ₹14.51B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ABVL | HGS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ABVL | HGS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 169,245 | 13,060 |
| Average Daily Volume (90 Day) | 387,234 | 13,539 |
| Shares Outstanding | 186.38M | 46.52M |
| Float Shares | 16.71M | 10.53M |
| % Held by Insiders | 0.75% | 0.79% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Arunjyoti Bio vs Hinduja Global
| Metric | ABVL | HGS |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹7.00 |
| Last 12-Month Dividend Yield | N/A | 1.29% |
| 3-Year Avg Annual Dividend | N/A | ₹15.67 |
| 3-Year Avg Dividend Yield | N/A | 0.65% |
| 3-Year Total Dividends | N/A | ₹47.00 |
| Ex-Dividend Date | N/A | Sep 19, 2024 |